Visa invents a method for rapid activation and provisioning of credit cards.
In this week’s featured patent applications, we cover the latest from Visa, Samsung, Apple, IBM, Boston Scientific, Abbott, Medtronic, Merck, Roche, and Novartis.
Visa Files a Patent Application for Rapid Activation and Provisioning of Payment Devices
U.S. patent application, US20200349549, discloses a method to rapidly activate payment devices, such as credit cards, with a mobile device. The method includes receiving an activation request from a user device in response to scanning an activation element, which includes user identification and card activation data. If the user identification and activation data match, the payment card is activated. A simple block diagram of the concept is illustrated below.
Samsung Seeks a Patent for a Device for Assisting with Driving a Vehicle
U.S. patent application, US0200346663, discloses a device that includes a communicator and a processor configured to determine whether an object in a driving environment is in a dangerous situation, determine a message type for notifying the object situation to the vehicle, and transmit a message through the communicator. The illustration below depicts the electronic device transmitting an emergency message.
IBM Eyes a Patent for Real Time Estimation of Indoor Lighting Conditions
U.S. patent application, US20200349693, discloses a method for estimating an outdoor sunlight density upon acquiring an image from a camera at a location within an indoor space at a specific time, calculating an indoor daylight index for the indoor space in real-time based on the outdoor sunlight density and the daylight factors corresponding to the characteristics of the indoor space and presenting the indoor daylight index to a user in the real-time. The figure below illustrates an example of a calculation of the indoor light index.
Apple Aims to Patent a Method for Locating Content in an Environment
U.S. patent application, US20200351608, discloses a method for locating an electronic device and obtaining a content item to be displayed by the electronic device. The method also determines a position and an orientation of the content to display the content item.
Boston Scientific Seeks a Patent for Real-Time Biopsy Needle and Target Tissue Visualization
U.S. patent application, US20200345334, relates to a pulmonary endoscopy tissue sampling system that allows a medical professional to visualize the location of a biopsy needle and target tissue in real-time before the needle actuation. The figure below illustrates visualizing a target pulmonary nodule and tissue sampling.
Abbott Wants to Patent a Sensor Inserter Assembly
U.S. patent application, US20200345282, discloses a sensor system for monitoring in vivo glucose or lactate levels having an inserter device with a retractable introducer to insert a subcutaneously implantable electrochemical sensor. The figure below illustrates a commercial exemplary sensor inserter.
Medtronic Seeks a Patent for an Oral Patient Tracking Device
U.S. patent application, US20200345425, discloses a patient tracking device including a conformable 3D pallet shaped sensor housing and a wireless electromagnetic sensor to track the patient’s movement during a procedure. The figures below illustrate the patient having the sensor housing and an environmental view of using the tracking device.
Merck Files a Patent Application for Substituted Tetrahydroisoquinoline Compounds as G-Protein Coupled Receptor Agonists
U.S. patent application, US20200347020, discloses methods of treating diabetes, obesity, hyperlipidemia, and inflammation-related disorders by administering substituted tetrahydroisoquinoline compounds to a patient. The compound has the below formula:
Roche Seeks a Patent for T Cell Activating Antigen Binding Molecules
U.S. patent application, US20200347147, relates to a method of cancer treatment by parenteral administration of novel bispecific T-cell activating antigen binding molecules in combination with a pharmaceutically acceptable carrier molecule.
Novartis Eyes a Patent for Oxazine Derivatives
U.S. patent application, US20200345746, discloses a method of preventing Alzheimer’s disease through the oral administration of an oxazine derivative, beta-site-APP cleaving enzyme-1 inhibitor in combination with itraconazole or rifampicin.